日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Disrupted Federal Funding for Extramural Cancer Research

联邦政府对院外癌症研究的资助中断

Haque, Waqas; Haque, Eman; Espinoza, Magdalena; Hsiehchen, David

Primary and secondary pseudo-stability and progression after atezolizumab with and without bevacizumab

阿特珠单抗联合或不联合贝伐珠单抗治疗后的原发性和继发性假性稳定性及疾病进展

Govindu, Saiabhiroop; Gowda, Prashanth; Muquith, Maishara; Espinoza, Magdalena; Hsiehchen, David

Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes

利用深度学习分析肿瘤中B细胞库的抗原结合亲和力,可预测免疫检查点抑制剂的治疗效果

Song, Bing; Wang, Kaiwen; Na, Saiyang; Yao, Jia; Fattah, Farjana J; Martin, Alexandra L; von Itzstein, Mitchell S; Yang, Donghan M; Liu, Jialiang; Xue, Yaming; Liang, Chaoying; Guo, Yuzhi; Raman, Indu; Zhu, Chengsong; Dowell, Jonathan E; Homsi, Jade; Rashdan, Sawsan; Yang, Shengjie; Gwin, Mary E; Wu, Tuoqi; Hsiehchen, David; Gloria-McCutchen, Yvonne; Lu, Catherine Pei-Ju; Raj, Prithvi; Bai, Xiao-Chen; Wang, Jun; Conejo-Garcia, Jose; Xie, Yang; Huang, Junzhou; Gerber, David E; Wang, Tao

Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial

在对PD-1抑制剂治疗耐药的肝细胞癌中,采用domvanalimab联合zimberelimab进行TIGIT和PD-1双重阻断治疗:LIVERTI II期试验

Hsiehchen, David; Kainthla, Radhika; Kline, Heather; Siglinsky, Ellen; Ahn, Chul; Zhu, Hao

Innate and adaptive immune features associated with immune-related adverse events

与免疫相关不良事件相关的先天性和适应性免疫特征

Khan, Shaheen; Malladi, Venkat S; von Itzstein, Mitchell S; Mu-Mosley, Hong; Fattah, Farjana J; Liu, Yang; Gwin, Mary E; Park, Jason Y; Cole, Suzanne M; Bhalla, Sheena; Lohrey, Jay; Hsiehchen, David; Moses, Angela; Wang, Tao; Xue, Yaming; Mobley, Angela B; Farrar, J David; Imam, Marjaan; Wu, Michelle; Li, Quan-Zhen; Wakeland, Edward K; Xie, Yang; SoRelle, Jeffrey A; Gerber, David E

Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients.

对 16,812 例晚期癌症患者的血浆游离 DNA 变异体进行表征,以确定其是肿瘤来源还是克隆性造血来源

Magee Daniel, Domenyuk Valeriy, Abraham Jim, Perdigones Borderias Nieves, Swensen Jeff, Solipuram Praveena, Ayanambakkam Adanma, Mehdi Raja, Challagalla Jagathi, Heath Elisabeth, Landsverk Megan, Jurkiewicz Magdalena, Shimkus Brian, Pinto Ian, Patterson Daniel, Hsiehchen David, Koya Supriya, Somer Bradley, Velez Michel, Shields Anthony F, Cultrera Jennifer, Ribeiro Jennifer R, Hahn-Lowry Robert, Sledge George W, Oberley Matthew, Radovich Milan, Spetzler David

Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma

肝细胞癌患者对免疫疗法的完全反应

Lim, Mir; Espinoza, Magdalena; Huang, Yi-Hsiang; Franses, Joseph; Zhu, Hao; Hsiehchen, David

Chemoprevention of hepatocellular carcinoma using N-acetylgalactosamine-conjugated siRNAs

利用N-乙酰半乳糖胺偶联siRNA进行肝细胞癌化学预防

Gianna Maggiore,Meng-Hsiung Hsieh,Amaey Bellary,Purva Gopal,Lin Li,Jason Guo,David Hsiehchen,Tulin Dadali,Wendy Broom,Martin Maier,Hao Zhu

Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer

肺癌患者系统性免疫参数的种族差异

von Itzstein, Mitchell S; Liu, Jialiang; Mu-Mosley, Hong; Fattah, Farjana; Park, Jason Y; SoRelle, Jeffrey A; Farrar, J David; Gwin, Mary E; Hsiehchen, David; Gloria-McCutchen, Yvonne; Wakeland, Edward K; Cole, Suzanne; Bhalla, Sheena; Kainthla, Radhika; Puzanov, Igor; Switzer, Benjamin; Daniels, Gregory A; Zakharia, Yousef; Shaheen, Montaser; Zhang, Jianjun; Xie, Yang; Gerber, David E

Racial and Ethnic Disparities in Survival among Patients with Cholangiocarcinoma in the United States: A Systematic Review and Meta-analysis

美国胆管癌患者生存率的种族和民族差异:系统评价和荟萃分析

Shubin, Andrew D; Leff, Phillip J; Tadros, Meena M; Hsieh, Meng L; Hsiehchen, David; Vagefi, Parsia A; Wang, Jason Y; Sapisochin, Gonzalo; Yopp, Adam C; Sanford, Nina N; Yang, Ju Dong; Singal, Amit G; Patel, Madhukar S; Rich, Nicole E